HIV replication and evolution in patients on highly active antiretroviral therapy

Podobne zapisy

• Antiretroviral dynamics determines HIV evolution and predicts therapy outcome
  od: Rosenbloom, Daniel I. S., i wsp.
  Wydane: (2012)
• MHC class II genotype and the control of viremia in HIV-1–infected individuals on highly active antiretroviral therapy
  od: Blankson, Joel N., i wsp.
  Wydane: (2001)
• Immune-based therapy using gamma interferon ingaron in the treatment of HIV/AIDS patients with active pulmonary tuberculosis (PTB) not previously highly active antiretroviral therapy (HAART)
  od: Yola, Auwal, i wsp.
  Wydane: (2006)
• Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
  od: Dinoso, J. B., i wsp.
  Wydane: (2009)
• Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS
  od: Rueda, Sergio, i wsp.
  Wydane: (2006)